IDSA and the HIVMA welcome the U.S. Preventive Services Task Force’s updated statement reaffirming and expanding its Grade A recommendation for pre-exposure prophylaxis for the prevention of HIV among adolescents and adults.

The Senate’s FY 2024 Labor, Health and Human Services and State and Foreign Operations appropriations bills largely flat fund ID programs at FY 2023 levels and provide a few modest increases.

Dr. Marrazzo is an exceptional infectious diseases physician, leader, mentor and scientist who has dedicated her career to key areas of research, including sexually transmitted infections, HIV and antimicrobial resistance.

Breakthrough research presented at the International AIDS Society’s 2023 Conference on HIV Science in Brisbane, Australia this week demonstrates the significant advances and scientific achievements recently made in HIV science.

IDSA and the HIVMA welcome President Biden’s appointment of Dr. Mandy Cohen to lead the U.S. Centers for Disease Control and Prevention. As the nation’s public health agency, CDC has a vital role in ensuring current and future health and preparedness.

IDSA is presenting its “2023 Legislative Impact Awards” to a bipartisan group of U.S. senators and representatives who have successfully led the passage of a new law or secured increased federal resources to address top IDSA priorities, including supporting the ID/HIV workforce and combating antimicrobial resistance.

The IDSA Foundation has named the George W. Counts, MD, FIDSA, Executive Conference room in honor of one of the country’s leading physicians, researchers, teachers, mentors and leaders.

The IDSA Foundation honored the memory of John Bartlett, MD, and his spouse Jean by dedicating a special member lounge in their names.